NCT06787547 (COCALP) is a NA clinical trial of IVL(Sonico-CX) in Calcified Coronary Lesions, sponsored by Spectrumedics Medical Technology(Shanghai)Co.,Ltd.

Who is sponsoring NCT06787547?

NCT06787547 is sponsored by Spectrumedics Medical Technology(Shanghai)Co.,Ltd.

What drugs are being tested in NCT06787547?

Interventions in NCT06787547: IVL(Sonico-CX).

What condition does NCT06787547 study?

NCT06787547 studies Calcified Coronary Lesions.

Is NCT06787547 still recruiting?

NCT06787547 is currently completed. Last updated 22 January 2025.

Last reviewed 2025-01-22 · How we verify

NCT06787547: COCALP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness and Safety of a Novel Intravascular Lithotripsy System in Severely Calcified Coronary Lesions(COCALP)

Completed NA Last updated 22 January 2025

What this trial tests

NA trial testing IVL(Sonico-CX) in Calcified Coronary Lesions in 266 participants. Completed in 31 May 2023.

Timeline

1 December 2021

Primary endpoint
29 November 2022

31 May 2023

Quick facts

Lead sponsor	Spectrumedics Medical Technology(Shanghai)Co.,Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	266
Start date	1 December 2021
Primary completion	29 November 2022
Estimated completion	31 May 2023
Sites	11 locations across China

Drugs / interventions tested

IVL(Sonico-CX)

Conditions studied

Calcified Coronary Lesions — all drugs for Calcified Coronary Lesions →

Sponsor

Spectrumedics Medical Technology(Shanghai)Co.,Ltd

Who can join

18 and older, any sex, with Calcified Coronary Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective, multicenter, single-arm trial designed to investigate the effectiveness and safety of this intravascular lithotripsy system to treat severely calcified coronary lesions before stenting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Calcified Coronary Lesions

Currently open trials in the same condition.

NCT07093788 — Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions · NA · recruiting

Other Spectrumedics Medical Technology(Shanghai)Co.,Ltd trials

Trials by the same sponsor.

NCT07109479 — Safety and Effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter Combined With the Intrava · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06787547 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Spectrumedics Medical Technology(Shanghai)Co.,Ltd
Last refreshed: 22 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06787547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing